Serum Ceruloplasmin Is the Candidate Predictive Biomarker for Acute Aortic Dissection and Is Related to Thrombosed

Changcheng Ma1, Haibin Zhao2, Feng Shi3

  • 1Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, China.

Insights

Serum ceruloplasmin (CP) levels are significantly elevated in patients with acute aortic dissection (AAD). This study suggests CP may be a valuable biomarker for diagnosing AAD and predicting thrombosed false lumen risk.

Area of Science:

  • Vascular Surgery
  • Biochemistry
  • Medical Diagnostics

Background:

  • Acute aortic dissection (AAD) is a life-threatening vascular emergency with high early mortality.
  • Ceruloplasmin (CP), a copper-transporting protein, has potential roles in inflammatory and cardiovascular conditions.

Purpose of the Study:

  • To investigate serum CP levels in patients with AAD.
  • To evaluate the diagnostic and prognostic value of CP in AAD.

Main Methods:

  • Retrospective study utilizing propensity score matching (PSM) to compare 85 pairs of AAD cases and controls.
  • Serum CP levels measured by ELISA.
  • Clinical data including inflammatory markers and dissection characteristics analyzed.

Main Results:

  • Serum CP levels were significantly higher in AAD patients compared to controls after PSM adjustment.
  • CP levels showed a positive correlation with platelet and C-reactive protein.
  • Receiver operating characteristic (ROC) analysis indicated CP as a strong diagnostic marker for AAD (AUC = 0.929).
  • Elevated CP levels were associated with an increased risk of thrombosed false lumen.

Conclusions:

  • Serum CP is significantly elevated in AAD patients.
  • CP correlates with inflammatory markers and may serve as a diagnostic biomarker for AAD.
  • CP may help identify patients at higher risk for thrombosed false lumen.